ACC 2006

Primary Angioplasty: Sirolimus Eluting Stent Cuts MACE Rates In Half

Christian Spaulding
Christian Spaulding, Rene Descartes University
American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta
Primary PCI is even more effective for treating myocardial infarction if a drug-eluting stent is used. That’s the finding from the French TYPHOON study just announced in Atlanta. The results show that a sirolimus eluting stent cut the incidence of major adverse cardiac events after one year by half. Christian Spaulding talked to Sarah Maxwell at the ACC conference.

Similar Interviews

  • Audio Journal of Cardiovascular Medicine: Sirolimus-Eluting Better Than Uncoated Stents for Primary Angioplasty">Audio Journal of Cardiovascular Medicine: Sirolimus-Eluting Better Than Uncoated Stents for Primary Angioplasty
  • CHRISTIAN SPAULDING, Cochin Hospital, Paris REFERENCE: N Engl J Med 2006;355:1093, 1105,1169 Two leading articles in the same edition of the New

  • Sirolimus Eluting Stent Superior in Meta Analysis
  • Antonio Abbate, Medical College of Virginia, Richmond American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta. Abstract Number: 2912-74 Even

  • ENDEAVOR or Cypher? Comparison of Drug Eluting Stents
  • The ABT578-eluting ENDEAVOR stent has been compared head-to-head with sirolimus-eluting Cypher. Duke University's David Kandzari told us more. [audio:http://www.audiomedica.com/podcasting/aha2005/David_Kandzari.mp3]Click here for

    Post a comment

    Subscribe to Audio Medica Podcast